Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
China NT Pharma Group Co., Ltd. ( (HK:1011) ) has provided an announcement.
China NT Pharma Group Co., Ltd. has announced a monthly update regarding their connected transaction involving loan capitalization through share subscription under a specific mandate. The company has applied for a Whitewash Waiver and received consent to extend the deadline for dispatching the relevant Circular to 28 January 2025. Completion of the subscription is contingent on the approval of independent shareholders and the granting of the Whitewash Waiver, with further announcements to follow upon finalization.
More about China NT Pharma Group Co., Ltd.
YTD Price Performance: -7.41%
Average Trading Volume: 278,256
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: HK$62.07M
See more insights into 1011 stock on TipRanks’ Stock Analysis page.
